CYBILL THOMAS: Open Payments
NPI 1285821603 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 28 payments from 14 companies in 2025. Trend: 2023 $989 · 2024 $805 · 2025 $688
Food & beverage: $634Education: $54
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $158 |
| Madrigal Pharmaceuticals | 2 | $75 |
| Janssen Biotech, Inc. | 2 | $73 |
| QOL Medical, LLC | 2 | $64 |
| Phathom Pharmaceuticals, Inc. | 5 | $64 |
| ABBVIE INC. | 3 | $61 |
| Novo Nordisk Inc | 2 | $49 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Amgen Inc. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
Products named: ENTYVIO, REZDIFFRA, TREMFYA, Sucraid, VOQUEZNA, Wegovy, CREON, LIVTENCITY.
Industry payments across CT — which companies pay providers there.
